Marco Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.77M Sell
134,125
-4,384
-3% -$117K 0.28% 72
2025
Q4
$3.45M Buy
138,509
+300
+0.2% +$7.57K 0.26% 74
2025
Q3
$3.52M Sell
138,209
-300
-0.2% -$7.41K 0.27% 74
2025
Q2
$3.36M Sell
138,509
-8,764
-6% -$204K 0.28% 75
2025
Q1
$3.73M Buy
147,273
+741
+0.5% +$19.4K 0.35% 63
2024
Q4
$3.89M Sell
146,532
-1,900
-1% -$51.5K 0.34% 66
2024
Q3
$4.3M Buy
148,432
+5,100
+4% +$149K 0.37% 64
2024
Q2
$4.01M Buy
143,332
+6,522
+5% +$180K 0.37% 60
2024
Q1
$3.8M Buy
136,810
+1,050
+0.8% +$29.1K 0.36% 65
2023
Q4
$3.91M Sell
135,760
-2,108
-2% -$63.7K 0.4% 61
2023
Q3
$4.57M Sell
137,868
-3,278
-2% -$116K 0.53% 55
2023
Q2
$5.18M Sell
141,146
-8,823
-6% -$343K 0.56% 53
2023
Q1
$6.12M Sell
149,969
-6,949
-4% -$300K 0.69% 44
2022
Q4
$8.04M Buy
156,918
+786
+0.5% +$37.7K 0.94% 33
2022
Q3
$6.83M Sell
156,132
-934
-0.6% -$45.4K 0.87% 39
2022
Q2
$8.23M Buy
157,066
+8,742
+6% +$445K 0.96% 33
2022
Q1
$7.68M Sell
148,324
-1,398
-0.9% -$72.5K 0.78% 41
2021
Q4
$8.84M Buy
149,722
+435
+0.3% +$21.6K 0.87% 38
2021
Q3
$6.42M Sell
149,287
-1,475
-1% -$65.3K 0.71% 41
2021
Q2
$5.9M Buy
150,762
+4,908
+3% +$191K 0.69% 41
2021
Q1
$5.28M Buy
145,854
+17,570
+14% +$624K 0.69% 40
2020
Q4
$4.72M Sell
128,284
-2,386
-2% -$87.5K 0.68% 43
2020
Q3
$4.55M Buy
130,670
+10,493
+9% +$368K 0.75% 40
2020
Q2
$3.73M Sell
120,177
-2,529
-2% -$85.9K 0.68% 42
2020
Q1
$3.8M Sell
122,706
-2,547
-2% -$86.8K 0.81% 39
2019
Q4
$4.66M Sell
125,253
-9,071
-7% -$323K 0.72% 43
2019
Q3
$4.58M Buy
134,324
+542
+0.4% +$19.7K 0.78% 42
2019
Q2
$5.5M Sell
133,782
-741
-0.6% -$29.4K 0.98% 35
2019
Q1
$5.42M Sell
134,523
-8,586
-6% -$344K 1.01% 31
2018
Q4
$5.93M Sell
143,109
-10,818
-7% -$449K 1.18% 26
2018
Q3
$6.44M Sell
153,927
-66
-0% -$2.54K 0.92% 36
2018
Q2
$5.3M Sell
153,993
-8,241
-5% -$282K 0.82% 43
2018
Q1
$5.46M Buy
162,234
+527
+0.3% +$18.1K 0.85% 40
2017
Q4
$5.56M Sell
161,707
-5,855
-3% -$200K 0.85% 42
2017
Q3
$5.67M Sell
167,562
-5,633
-3% -$181K 0.89% 41
2017
Q2
$5.52M Buy
173,195
+477
+0.3% +$15K 0.91% 41
2017
Q1
$5.61M Sell
172,718
-2,337
-1% -$73.7K 0.95% 40
2016
Q4
$5.39M Buy
175,055
+4,992
+3% +$152K 0.94% 39
2016
Q3
$5.46M Sell
170,063
-2,384
-1% -$79.7K 0.98% 37
2016
Q2
$5.76M Sell
172,447
-2,262
-1% -$72.2K 1.07% 33
2016
Q1
$4.91K Buy
174,709
+24,245
+16% +$693K 0.71% 41
2015
Q4
$4.61M Buy
150,464
+17,920
+14% +$564K 0.86% 39
2015
Q3
$3.95M Buy
132,544
+9,753
+8% +$313K 0.78% 43
2015
Q2
$3.91M Buy
122,791
+545
+0.4% +$17.8K 0.65% 56
2015
Q1
$4.04M Buy
122,246
+4,278
+4% +$136K 0.7% 52
2014
Q4
$3.49M Sell
117,968
-859
-0.7% -$24.6K 0.44% 61
2014
Q3
$3.33M Sell
118,827
-7,639
-6% -$214K 0.46% 58
2014
Q2
$3.56M Buy
126,466
+1,131
+0.9% +$32.2K 0.68% 53
2014
Q1
$3.82M Sell
125,335
-387
-0.3% -$11.5K 0.8% 50
2013
Q4
$3.65K Sell
125,722
-6,693
-5% -$195K 0.19% 50
2013
Q3
$3.61M Sell
132,415
-154
-0.1% -$4.19K 0.83% 44
2013
Q2
$3.52M Buy
+132,569
New +$3.66M 1.02% 35

Other funds holding PFE

Marco Investment Management's PFE Position: Q1 2026 in Review

Marco Investment Management reduced its Pfizer (PFE) stake by 3.2% in Q1 2026, selling an estimated $117K and leaving 134,125 shares worth $3.77M. The position accounts for 0.28% of the portfolio, ranked #72.

Marco Investment Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.84M in Q4 2021. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Marco Investment Management held 134,125 shares of Pfizer worth $3.77M as of Q1 2026.
  • Marco Investment Management sold 4,384 Pfizer shares in Q1 2026, an estimated $117K.
  • Pfizer made up 0.28% of Marco Investment Management's portfolio in Q1 2026, its #72 holding.
  • Marco Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Marco Investment Management's Pfizer position peaked at $8.84M in Q4 2021.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Marco Investment Management's 13F filing for Q1 2026, filed 8 May 2026.